| PESAE15 | Amazon smart locker collaboration as a pick up point preference for medicine distribution programs in Sub-Saharan Africa | Poster exhibition | Innovations and lessons for supporting HIV prevention effective use and treatment adherence |
| PESUE17 | Triangulating orphans and vulnerable children program and health facility data to improve HIV treatment outcomes for children and adolescents living with HIV | Poster exhibition | Innovations and lessons for supporting HIV prevention effective use and treatment adherence |
| PESUE18 | Take home dose of Methadone: new arena for OST adherence during COVID-19 in Bangladesh | Poster exhibition | Innovations and lessons for supporting HIV prevention effective use and treatment adherence |
| EPA021 | HIV-1 subtype C Vif transmitted/founder (T/F) variants preferentially degrade APOBEC3G over APOBEC3F | E-poster | Innate immunity (including NK cells) |
| EPA022 | Impact of chronic HIV infection on NK cell response through the HLA-E/NKG2x axis | E-poster | Innate immunity (including NK cells) |
| EPA023 | Immunotherapeutic blockades targeting LAG-3 and PD-1 immune checkpoint inhibitors on invariant Natural Killer T cells: implications in chronic HIV infection | E-poster | Innate immunity (including NK cells) |
| EPA024 | The effects of in utero HIV and anti-retroviral therapy exposure on infant T-cell and monocyte activation, function and regulation of immune-modulatory pathways | E-poster | Innate immunity (including NK cells) |
| EPA025 | HLA-B*46 associates with rapid HIV disease progression in Asian cohorts and prominent differences in NK cell phenotypes | E-poster | Innate immunity (including NK cells) |
| EPA026 | Characterizing the effect of intracellular storage pools of RANTES/CCL5 on HIV infection in macrophages | E-poster | Innate immunity (including NK cells) |
| EPLBA08 | ILC3s in HIV-infected lymph nodes up-regulate inflammatory pathways linked to tissue fibrosis | E-poster | Innate immunity (including NK cells) |